Duke Surgical Oncology/X
Mar 30, 2025, 17:46
Thought-provoking trial on localized pancreatic cancer presented by Ethan Agritelley at SSO2025 – Duke Surgical Oncology
Duke Surgical Oncology shared a post on X:
“Thought-provoking trial of single-dose neoadjuvant hepatic artery chemo for localized pancreatic cancer ongoing at Duke University Department of Surgery, Duke Cancer Institute, led by Dr. Daniel Nussbaum and presented by Duke University School of Medicine student Ethan Agritelley at SSO2025.”
More posts featuring Duke Surgical Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 1, 2025, 09:06
Sep 1, 2025, 08:55
Sep 1, 2025, 08:47
Sep 1, 2025, 08:39
Sep 1, 2025, 08:30
Sep 1, 2025, 07:34
Sep 1, 2025, 07:27
Sep 1, 2025, 07:26